| Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study MA Amiche, S Abtahi, JHM Driessen, P Vestergaard, F de Vries, ... Archives of Osteoporosis 13, 1-10, 2018 | 54 | 2018 |
| Secular trends in major osteoporotic fractures among 50+ adults in Denmark between 1995 and 2010 S Abtahi, JHM Driessen, P Vestergaard, J van den Bergh, A Boonen, ... Osteoporosis International 30 (11), 2217-2223, 2019 | 49* | 2019 |
| Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study S Abtahi, JHM Driessen, AM Burden, PC Souverein, JP van den Bergh, ... Annals of the rheumatic diseases 80 (4), 423-431, 2021 | 29 | 2021 |
| Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink S Abtahi, JHM Driessen, AM Burden, PC Souverein, JP van den Bergh, ... Rheumatology 61 (4), 1448-1458, 2022 | 17 | 2022 |
| The association of oral bisphosphonate use with mortality risk following a major osteoporotic fracture in the United Kingdom: population-based cohort study S Abtahi, AM Burden, P Geusens, JP van den Bergh, T van Staa, ... Journal of the American Medical Directors Association 21 (6), 811-816, 2020 | 12 | 2020 |
| Biological disease-modifying antirheumatic drugs and osteoporotic fracture risk in patients with rheumatoid arthritis: a Danish cohort study S Abtahi, R Cordtz, L Dreyer, JHM Driessen, A Boonen, AM Burden The American Journal of Medicine 135 (7), 879-888. e3, 2022 | 11 | 2022 |
| Illness perception of patients with pemphigus vulgaris M Nasimi, R Abedini, M Daneshpazjooh, A Esmaeilpour, F Ghaedi, ... International Journal of Women's Dermatology 5 (2), 96-99, 2019 | 10 | 2019 |
| Distinguishing immunohistochemical features of alopecia areata from androgenic alopecia K Kamyab, M Rezvani, H Seirafi, S Mortazavi, A Teymourpour, S Abtahi, ... Journal of Cosmetic Dermatology 18 (1), 422-426, 2019 | 7 | 2019 |
| Impact of 2018 EU risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of medicinal products containing valproate: an … S Abtahi, R Pajouheshnia, CE Durán, J Riera-Arnau, M Gamba, E Alsina, ... Drug Safety 46 (7), 689-702, 2023 | 5 | 2023 |
| Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint … A van Veelen, S Abtahi, P Souverein, JHM Driessen, OH Klungel, ... Cancer Epidemiology 78, 102149, 2022 | 4 | 2022 |
| Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy … CE Durán, J Riera-Arnau, S Abtahi, R Pajouheshnia, V Hoxhaj, M Gamba, ... Frontiers in Pharmacology 14, 1207976, 2023 | 2 | 2023 |
| Psoralen and ultraviolet A in atopic dermatitis S Abtahi, H Seirafi, K Balighi, AH Ehsani, F Farnaghi, P Mobasher Journal of Skin and Stem Cell 4 (2), 2017 | 2 | 2017 |
| Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders DHT Tsai, JS Bell, S Abtahi, BN Baak, MT Bazelier, R Brauer, AYL Chan, ... Clinical epidemiology, 1241-1252, 2023 | 1 | 2023 |
| The role of misclassification of exposure in the association between aspirin and nonsteroidal anti‐inflammatory drug use and keratinocyte cancers. S Abtahi, OA Oshagbemi, A Veelen, R Geel British Journal of Dermatology 181 (3), 2019 | 1 | 2019 |
| The role of long‐term effects of allopurinol on cardiovascular outcomes and all‐cause mortality in diabetes. S Abtahi Diabetes, Obesity & Metabolism 21 (9), 2019 | 1 | 2019 |
| Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions–A cross-sectional … C Buhl, R Jacobsen, AB Almarsdóttir, S Abtahi, A Andersen, E Deligianni, ... Vaccine 42 (3), 556-563, 2024 | | 2024 |
| Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy … J Riera-Arnau, V Hoxhaj, M Gamba, M Sabaté, E Ballarín, CE Durán, ... Frontiers Media, 2023 | | 2023 |
| Response to:‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis … S Abtahi, JHM Driessen, AM Burden, PC Souverein, JP Van Den Bergh, ... Annals of the rheumatic diseases 82 (6), e143-e143, 2023 | | 2023 |
| Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates S Abtahi, R Pajouheshnia, C Duran-Salinas, J Riera-Arnau, M Gamba, ... Drug Safety 45 (10), 1312-1313, 2022 | | 2022 |
| Oral Presentation: Impact of the 2018 Pregnancy Prevention Program on the Use of Oral Retinoids in Childbearing Age Females in Europe C Duran, JR Arnau, S Abtahi, R Pajouheshnia, M Gamba, P García, ... Drug Safety 45 (10), 1118-1119, 2022 | | 2022 |
Frank de VriesProfessor Emeritus, The NetherlandsGeverifieerd e-mailadres voor fdevries.com
